Pulminiq Is “Approvable” At FDA; Confirmatory Trial Is Needed
This article was originally published in The Pink Sheet Daily
Executive Summary
Chiron will evaluate next steps before making any decisions regarding the aerosolized cyclosporine therapy. FDA is requiring a clinical trial to confirm the efficacy of Pulminiq demonstrated in a single Phase II trial.